1
|
Al-Tawalbeh DM, Alawneh JM, Momani W, Mayyas A. Comparative antibacterial activity of clove extract against Pseudomonas aeruginosa. BMC Complement Med Ther 2025; 25:7. [PMID: 39789583 PMCID: PMC11716342 DOI: 10.1186/s12906-024-04740-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2024] [Accepted: 12/20/2024] [Indexed: 01/12/2025] Open
Abstract
Pseudomonas aeruginosa is an opportunistic pathogen belonging to the γ-proteobacteria family, known to cause pneumonia linked with ventilator use and nosocomial infections. With the increasing prevalence of antibiotic-resistant bacteria, there is a pressing need to identify alternatives to conventional antibiotics. Plant-derived substances (PDSs) offer potential not only as antibacterial agents but also as modulators of antibiotic resistance. In this study, diffusion assay using disc agar, and the minimum inhibitory concentration (MIC) assay of each imipenem, amoxicillin-clavulanic acid, and clove extract was determined. The clove extract was analyzed via the UHPLC/MS, and the checkerboard assay was employed to evaluate the potential synergistic effects of combining clove extract with both antibiotics. The combination of clove extract to each antibiotic led to a significant reduction in their respective MICs. Moreover, each antibiotic exhibited synergistic effects on the fractional inhibitory concentration value (FIC) of clove extract. The analysis identified seventeen components in the clove extract, predominantly flavonoids and phenolic compounds. The antibacterial efficacy of the Syzygium aromaticum Myrtaceae extract against P. aeruginosa indicated its potential as a promising antibacterial agent capable of enhancing the effectiveness of existing medications.
Collapse
Affiliation(s)
- Deniz M Al-Tawalbeh
- Department of Medicinal Chemistry and Pharmacognosy, Faculty of Pharmacy, Yarmouk University, Irbid, Jordan.
| | - Jafar M Alawneh
- Department of Medical Laboratory Sciences, Faculty of Allied Medical Sciences, Jadara University, Irbid, Jordan
| | - Waleed Momani
- Department of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid, Jordan
| | - Amal Mayyas
- Department of Faculty of Health Sciences, American University of Madaba, Madaba, Jordan
| |
Collapse
|
2
|
Daniell H, Guo Y, Singh R, Karki U, Kulchar RJ, Wakade G, Pihlava JM, Khazaei H, Cohen GH. Debulking influenza and herpes simplex virus strains by a wide-spectrum anti-viral protein formulated in clinical grade chewing gum. Mol Ther 2025; 33:184-200. [PMID: 39663701 DOI: 10.1016/j.ymthe.2024.12.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2024] [Revised: 09/17/2024] [Accepted: 12/06/2024] [Indexed: 12/13/2024] Open
Abstract
Lack of Herpes Simplex Virus (HSV) vaccine, low vaccination rates of Influenza viruses, waning immunity and viral transmission after vaccination underscore the need to reduce viral loads at their transmission sites. Oral virus transmission is several orders of magnitude higher than nasal transmission. Therefore, in this study, we evaluated neutralization of viruses using a natural viral trap protein (FRIL) formulated in clinical-grade chewing gum. FRIL is highly stable in the lablab bean powder (683 days) and in chewing gum (790 days), and fully functional (794 days) when stored at ambient temperature. They passed the bioburden test with no aerobic bacteria, yeasts/molds, with minimal moisture content (1.28-5.9%). Bean gum extracts trapped HSV-1/HSV-2 75-94% in a dose-dependent manner through virus self-aggregation. Mastication simulator released >50% release of FRIL within 15 min of chewing the bean gum. In plaque reduction assays, >95% neutralization of H1N1 and H3N2 required ∼40 mg/mL, HSV-1 160 mg/mL, and HSV-2 74 mg/mL of bean gum for 1,000 copies/mL virus particles. Therefore, a 2000 mg bean gum tablet has more than adequate potency for clinical evaluation and is safe with no detectable levels of glycosides. These observations augur well for evaluating bean gum in human clinical studies to minimize virus infection/transmission.
Collapse
Affiliation(s)
- Henry Daniell
- Department of Basic & Translational Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
| | - Yuwei Guo
- Department of Basic & Translational Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Rahul Singh
- Department of Basic & Translational Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Uddhab Karki
- Department of Basic & Translational Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Rachel J Kulchar
- Department of Basic & Translational Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Geetanjali Wakade
- Department of Basic & Translational Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| | | | - Hamid Khazaei
- Natural Resources Institute Finland (Luke), Helsinki, Finland; Department of Agricultural Sciences, University of Helsinki, Helsinki, Finland
| | - Gary H Cohen
- Department of Basic & Translational Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| |
Collapse
|
3
|
Ndossi BA, Mjingo EE, Park H, Lee D, Bia MM, Yang H, Seo S, Eom KS. Zoonotic Parasites and Their Association With Human Activities in Northern Tanzania: An Integrated Ecosystem Approach for One Health. J Parasitol Res 2024; 2024:8872837. [PMID: 39071810 PMCID: PMC11281853 DOI: 10.1155/2024/8872837] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2023] [Revised: 05/04/2024] [Accepted: 06/20/2024] [Indexed: 07/30/2024] Open
Abstract
The community's awareness of the prevalence and impact of zoonotic diseases has been significantly underestimated, leading to insufficient implementation of control measures. This study was carried out in Northern Tanzania between 2019 and 2023 to investigate zoonotic parasites and the risks associated with human activities that contribute to zoonotic diseases. Cross-sectional surveys were conducted in 12 villages, including nine in Loliondo Division and three in Babati District. Focus Group Discussions and Key Informant Interviews were conducted to assess the community's knowledge and practices regarding the risks associated with zoonotic diseases in the surveyed areas. A total of 255 samples were collected from various sources, including latrines, households, livestock enclosures, domestic dogs, and chickens. Out of these samples, 152 tested positive for identifiable parasite eggs and oocysts. These parasites included hookworms (21.7%), Trichuris sp. (14.5%), Strongyloides sp. (13.8%), Eimeria sp. (19.7%), Taeniids (5.9%), Hymenolepis sp. (3.3%), Spirometra sp. (2.6%), and Dipylidium sp. (0.7%). Taeniids and Spirometra species were predominantly found in villages near protected areas such as Arash Sokoni, Oloipiri, Sukenya, Wasso, Orkuyiene, Haytemba, and Loliondo. Hookworms were most commonly detected in Arash Sokoni, Loliondo, Isuguro, and Hyatemba, while Strongyloides sp. was prevalent in Wasso, Sukenya, and Olobo villages. The quantitative analysis reveals significant associations between hygiene practices, proximity to livestock enclosures, ecological factors, and human-animal interaction, highlighting their pivotal roles in determining soil-transmitted helminth (STH) prevalence across different villages. This study reveals that there was a generally low level of awareness regarding zoonotic diseases and STHs. The detection of STH samples, combined with the limited understanding of zoonotic diseases, emphasizes the importance of taking proactive measures to reduce transmission risks. Prioritizing education and promoting awareness along with implementing comprehensive strategies are essential steps to effectively tackle the problems linked to STH infections and substantially lessen the public health burden caused by zoonotic diseases.
Collapse
Affiliation(s)
- Barakaeli Abdieli Ndossi
- Tanzania Wildlife Research Institute, P.O. Box 661, Arusha, Tanzania
- Department of ParasitologyParasitology Research Center and International Parasite Resource BankChungbuk National UniversitySchool of Medicine, Cheongju 28644, Republic of Korea
| | | | - Hansol Park
- Department of ParasitologyParasitology Research Center and International Parasite Resource BankChungbuk National UniversitySchool of Medicine, Cheongju 28644, Republic of Korea
| | - Dongmin Lee
- Department of ParasitologyParasitology Research Center and International Parasite Resource BankChungbuk National UniversitySchool of Medicine, Cheongju 28644, Republic of Korea
| | - Mohammed Mebarek Bia
- Department of ParasitologyParasitology Research Center and International Parasite Resource BankChungbuk National UniversitySchool of Medicine, Cheongju 28644, Republic of Korea
| | - Heejae Yang
- Division of Biobanking SolutionsCocoon Inc. 116194-41, Uiryodanji-gil, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea
| | - Sungbo Seo
- Division of Biobanking SolutionsCocoon Inc. 116194-41, Uiryodanji-gil, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea
| | - Keeseon S. Eom
- Department of ParasitologyParasitology Research Center and International Parasite Resource BankChungbuk National UniversitySchool of Medicine, Cheongju 28644, Republic of Korea
| |
Collapse
|
4
|
Carmo dos Santos M, Cerqueira Silva AC, dos Reis Teixeira C, Pinheiro Macedo Prazeres F, Fernandes dos Santos R, de Araújo Rolo C, de Souza Santos E, Santos da Fonseca M, Oliveira Valente C, Saraiva Hodel KV, Moraes dos Santos Fonseca L, Sampaio Dotto Fiuza B, de Freitas Bueno R, Bittencourt de Andrade J, Aparecida Souza Machado B. Wastewater surveillance for viral pathogens: A tool for public health. Heliyon 2024; 10:e33873. [PMID: 39071684 PMCID: PMC11279281 DOI: 10.1016/j.heliyon.2024.e33873] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2024] [Revised: 06/03/2024] [Accepted: 06/28/2024] [Indexed: 07/30/2024] Open
Abstract
A focus on water quality has intensified globally, considering its critical role in sustaining life and ecosystems. Wastewater, reflecting societal development, profoundly impacts public health. Wastewater-based epidemiology (WBE) has emerged as a surveillance tool for detecting outbreaks early, monitoring infectious disease trends, and providing real-time insights, particularly in vulnerable communities. WBE aids in tracking pathogens, including viruses, in sewage, offering a comprehensive understanding of community health and lifestyle habits. With the rise in global COVID-19 cases, WBE has gained prominence, aiding in monitoring SARS-CoV-2 levels worldwide. Despite advancements in water treatment, poorly treated wastewater discharge remains a threat, amplifying the spread of water-, sanitation-, and hygiene (WaSH)-related diseases. WBE, serving as complementary surveillance, is pivotal for monitoring community-level viral infections. However, there is untapped potential for WBE to expand its role in public health surveillance. This review emphasizes the importance of WBE in understanding the link between viral surveillance in wastewater and public health, highlighting the need for its further integration into public health management.
Collapse
Affiliation(s)
- Matheus Carmo dos Santos
- SENAI Institute of Innovation (ISI) in Health Advanced Systems (CIMATEC ISI SAS), SENAI CI-MATEC, Salvador, 41650-010, Bahia, Brazil
| | - Ana Clara Cerqueira Silva
- SENAI Institute of Innovation (ISI) in Health Advanced Systems (CIMATEC ISI SAS), SENAI CI-MATEC, Salvador, 41650-010, Bahia, Brazil
| | - Carine dos Reis Teixeira
- SENAI Institute of Innovation (ISI) in Health Advanced Systems (CIMATEC ISI SAS), SENAI CI-MATEC, Salvador, 41650-010, Bahia, Brazil
| | - Filipe Pinheiro Macedo Prazeres
- SENAI Institute of Innovation (ISI) in Health Advanced Systems (CIMATEC ISI SAS), SENAI CI-MATEC, Salvador, 41650-010, Bahia, Brazil
| | - Rosângela Fernandes dos Santos
- SENAI Institute of Innovation (ISI) in Health Advanced Systems (CIMATEC ISI SAS), SENAI CI-MATEC, Salvador, 41650-010, Bahia, Brazil
| | - Carolina de Araújo Rolo
- SENAI Institute of Innovation (ISI) in Health Advanced Systems (CIMATEC ISI SAS), SENAI CI-MATEC, Salvador, 41650-010, Bahia, Brazil
| | - Emanuelle de Souza Santos
- SENAI Institute of Innovation (ISI) in Health Advanced Systems (CIMATEC ISI SAS), SENAI CI-MATEC, Salvador, 41650-010, Bahia, Brazil
| | - Maísa Santos da Fonseca
- SENAI Institute of Innovation (ISI) in Health Advanced Systems (CIMATEC ISI SAS), SENAI CI-MATEC, Salvador, 41650-010, Bahia, Brazil
| | - Camila Oliveira Valente
- SENAI Institute of Innovation (ISI) in Health Advanced Systems (CIMATEC ISI SAS), SENAI CI-MATEC, Salvador, 41650-010, Bahia, Brazil
| | - Katharine Valéria Saraiva Hodel
- SENAI Institute of Innovation (ISI) in Health Advanced Systems (CIMATEC ISI SAS), SENAI CI-MATEC, Salvador, 41650-010, Bahia, Brazil
| | - Larissa Moraes dos Santos Fonseca
- SENAI Institute of Innovation (ISI) in Health Advanced Systems (CIMATEC ISI SAS), SENAI CI-MATEC, Salvador, 41650-010, Bahia, Brazil
| | - Bianca Sampaio Dotto Fiuza
- SENAI Institute of Innovation (ISI) in Health Advanced Systems (CIMATEC ISI SAS), SENAI CI-MATEC, Salvador, 41650-010, Bahia, Brazil
| | - Rodrigo de Freitas Bueno
- Federal University of ABC. Center of Engineering, Modelling and Applied Social Sciences (CECS), Santo Andre, São Paulo, Brazil
| | - Jailson Bittencourt de Andrade
- University Center SENAI CIMATEC, SENAI CIMATEC, Salvador, 41650-010, Bahia, Brazil
- Centro Interdisciplinar de Energia e Ambiente – CIEnAm, Federal University of Bahia, Salvador, 40170-115, Brazil
| | - Bruna Aparecida Souza Machado
- SENAI Institute of Innovation (ISI) in Health Advanced Systems (CIMATEC ISI SAS), SENAI CI-MATEC, Salvador, 41650-010, Bahia, Brazil
- University Center SENAI CIMATEC, SENAI CIMATEC, Salvador, 41650-010, Bahia, Brazil
| |
Collapse
|
5
|
Song Q, Li Y, Cao L, Hao L, Wen N, Wang F, Ma C, Zhang G, Zheng H, Yu W, An Z, Yin Z, Wang H. Impact of National Immunization Strategies on Vaccine-Preventable Diseases - China, 1950-2021. China CDC Wkly 2024; 6:339-343. [PMID: 38736466 PMCID: PMC11082052 DOI: 10.46234/ccdcw2024.064] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2024] [Accepted: 03/18/2024] [Indexed: 05/14/2024] Open
Abstract
What is already known about this topic? The incidences of vaccine-preventable diseases (VPDs) included in the Expanded Program on Immunization in China have decreased significantly in recent decades. What is added by this report? This study summarizes the national incidences of nine VPDs and the seroprevalence of hepatitis B surface antigen (HBsAg) under different immunization strategies from 1950 through 2021 in China. The sharpest decreases in VPD incidence and under-5-year HBsAg seroprevalence occurred during the latest stage of the National Immunization Program. The decreases in VPD incidence were most prominent among children under five years of age. What are the implications for public health practice? These findings provide valuable insights for vaccine value assessment and emphasize the importance of implementing immunization strategies in targeted populations.
Collapse
Affiliation(s)
- Quanwei Song
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), Beijing, China
- National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
| | - Yixing Li
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), Beijing, China
- National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
| | - Lei Cao
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), Beijing, China
- National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
| | - Lixin Hao
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), Beijing, China
- National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
| | - Ning Wen
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), Beijing, China
- National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
| | - Fuzhen Wang
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), Beijing, China
- National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
| | - Chao Ma
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), Beijing, China
- National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
| | - Guomin Zhang
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), Beijing, China
- National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
| | - Hui Zheng
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), Beijing, China
- National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
| | - Wenzhou Yu
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), Beijing, China
- National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
| | - Zhijie An
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), Beijing, China
- National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
| | - Zundong Yin
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), Beijing, China
- National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
| | - Huaqing Wang
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), Beijing, China
- National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
| |
Collapse
|
6
|
Zhang L, Li MY, Zhi C, Zhu M, Ma H. Identification of Early Warning Signals of Infectious Diseases in Hospitals by Integrating Clinical Treatment and Disease Prevention. Curr Med Sci 2024; 44:273-280. [PMID: 38632143 DOI: 10.1007/s11596-024-2850-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2023] [Accepted: 02/19/2024] [Indexed: 04/19/2024]
Abstract
The global incidence of infectious diseases has increased in recent years, posing a significant threat to human health. Hospitals typically serve as frontline institutions for detecting infectious diseases. However, accurately identifying warning signals of infectious diseases in a timely manner, especially emerging infectious diseases, can be challenging. Consequently, there is a pressing need to integrate treatment and disease prevention data to conduct comprehensive analyses aimed at preventing and controlling infectious diseases within hospitals. This paper examines the role of medical data in the early identification of infectious diseases, explores early warning technologies for infectious disease recognition, and assesses monitoring and early warning mechanisms for infectious diseases. We propose that hospitals adopt novel multidimensional early warning technologies to mine and analyze medical data from various systems, in compliance with national strategies to integrate clinical treatment and disease prevention. Furthermore, hospitals should establish institution-specific, clinical-based early warning models for infectious diseases to actively monitor early signals and enhance preparedness for infectious disease prevention and control.
Collapse
Affiliation(s)
- Lei Zhang
- Sixth Medical Center, Chinese PLA General Hospital, Beijing, 100048, China
| | - Min-Ye Li
- The Nursing Department, Chinese PLA General Hospital, Beijing, 100853, China
| | - Chen Zhi
- The Nursing Department, Chinese PLA General Hospital, Beijing, 100853, China
| | - Min Zhu
- Sixth Medical Center, Chinese PLA General Hospital, Beijing, 100048, China
| | - Hui Ma
- The Nursing Department, Chinese PLA General Hospital, Beijing, 100853, China.
| |
Collapse
|
7
|
Rinaldi E, Drenkhahn C, Gebel B, Saleh K, Tönnies H, von Loewenich FD, Thoma N, Baier C, Boeker M, Hinske LC, Diaz LAP, Behnke M, Ingenerf J, Thun S. Towards interoperability in infection control: a standard data model for microbiology. Sci Data 2023; 10:654. [PMID: 37741862 PMCID: PMC10517923 DOI: 10.1038/s41597-023-02560-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2023] [Accepted: 09/12/2023] [Indexed: 09/25/2023] Open
Abstract
The COVID-19 pandemic has made it clear: sharing and exchanging data among research institutions is crucial in order to efficiently respond to global health threats. This can be facilitated by defining health data models based on interoperability standards. In Germany, a national effort is in progress to create common data models using international healthcare IT standards. In this context, collaborative work on a data set module for microbiology is of particular importance as the WHO has declared antimicrobial resistance one of the top global public health threats that humanity is facing. In this article, we describe how we developed a common model for microbiology data in an interdisciplinary collaborative effort and how we make use of the standard HL7 FHIR and terminologies such as SNOMED CT or LOINC to ensure syntactic and semantic interoperability. The use of international healthcare standards qualifies our data model to be adopted beyond the environment where it was first developed and used at an international level.
Collapse
Affiliation(s)
- Eugenia Rinaldi
- Berlin Institute of Health, Charité Universitätsmedizin, Berlin, Germany.
| | - Cora Drenkhahn
- Institute of Medical Informatics (IMI), University of Lübeck, Lübeck, Germany
| | - Benjamin Gebel
- Klinik für Infektiologie und Mikrobiologie, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Lübeck, Germany
| | - Kutaiba Saleh
- Data Integration Center, Jena University Hospital, Jena, Germany
| | | | | | - Norbert Thoma
- Institute for Hygiene and Environmental Medicine, Charité Universitätsmedizin, Berlin, Germany
| | - Claas Baier
- Hannover Medical School, Institute for Medical Microbiology and Hospital Epidemiology, Hannover, Germany
| | | | | | - Luis Alberto Peña Diaz
- Institute for Hygiene and Environmental Medicine, Charité Universitätsmedizin, Berlin, Germany
| | - Michael Behnke
- Institute for Hygiene and Environmental Medicine, Charité Universitätsmedizin, Berlin, Germany
| | - Josef Ingenerf
- Institute of Medical Informatics (IMI), University of Lübeck, Lübeck, Germany
| | - Sylvia Thun
- Berlin Institute of Health, Charité Universitätsmedizin, Berlin, Germany
| |
Collapse
|
8
|
Li Y, Xia X, Hou W, Lv H, Liu J, Li X. How Effective are Metal Nanotherapeutic Platforms Against Bacterial Infections? A Comprehensive Review of Literature. Int J Nanomedicine 2023; 18:1109-1128. [PMID: 36883070 PMCID: PMC9985878 DOI: 10.2147/ijn.s397298] [Citation(s) in RCA: 16] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2022] [Accepted: 02/19/2023] [Indexed: 03/05/2023] Open
Abstract
The emergence of multidrug-resistant bacteria has been deemed a global crisis that affects humans worldwide. Novel anti-infection strategies are desperately needed because of the limitations of conventional antibiotics. However, the increasing gap between clinical demand and antimicrobial treatment innovation, as well as the membrane permeability obstacle especially in gram-negative bacteria fearfully restrict the reformation of antibacterial strategy. Metal-organic frameworks (MOFs) have the advantages of adjustable apertures, high drug-loading rates, tailorable structures, and superior biocompatibilities, enabling their utilization as drug delivery carriers in biotherapy applications. Additionally, the metal elements in MOFs are usually bactericidal. This article provides a review of the state-of-The-art design, the underlying antibacterial mechanisms and antibacterial applications of MOF- and MOF-based drug-loading materials. In addition, the existing problems and future perspectives of MOF- and MOF-based drug-loading materials are also discussed.
Collapse
Affiliation(s)
- Ying Li
- Department of Stomatology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, People's Republic of China
- School of Stomatology, Qingdao University, Qingdao, People's Republic of China
| | - Xiaomin Xia
- Department of Stomatology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, People's Republic of China
- School of Stomatology, Qingdao University, Qingdao, People's Republic of China
| | - Wenxue Hou
- Department of Stomatology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, People's Republic of China
- School of Stomatology, Qingdao University, Qingdao, People's Republic of China
| | - Hanlin Lv
- Department of Stomatology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, People's Republic of China
- School of Stomatology, Qingdao University, Qingdao, People's Republic of China
| | - Jie Liu
- Department of Stomatology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, People's Republic of China
- School of Stomatology, Qingdao University, Qingdao, People's Republic of China
| | - Xue Li
- Department of Stomatology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, People's Republic of China
- School of Stomatology, Qingdao University, Qingdao, People's Republic of China
| |
Collapse
|
9
|
Traversi D, Ripabelli G. Editorial: New omics research challenges for Public and sustainable Health. Front Microbiol 2022; 13:1078865. [PMID: 36519159 PMCID: PMC9742550 DOI: 10.3389/fmicb.2022.1078865] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2022] [Accepted: 11/04/2022] [Indexed: 10/28/2023] Open
Affiliation(s)
- Deborah Traversi
- Department of Public Health and Pediatrics, Environmental Hygiene Laboratory, University of the Study of Turin, Turin, Italy
| | - Giancarlo Ripabelli
- Department of Medicine and Health Sciences “Vincenzo Tiberio”, University of Molise, Campobasso, Italy
| |
Collapse
|
10
|
Wei P, Wu L, Li Y, Shi J, Luo Y, Wu W, Feng J. Metagenomic next-generation sequencing for the detection of pathogenic microorganisms in patients with pulmonary infection. Am J Transl Res 2022; 14:6382-6388. [PMID: 36247251 PMCID: PMC9556471] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2022] [Accepted: 08/03/2022] [Indexed: 06/16/2023]
Abstract
OBJECTIVE To explore the clinical value of metagenomic next-generation sequencing (mNGS) in diagnosing pulmonary infectious diseases. METHODS A retrospective analysis was performed on 82 patients with pulmonary infection who were admitted to the Eighth Affiliated Hospital of Guangxi Medical University & Guigang City People's Hospital from January 2020 to December 2021. The pathogens were detected by mNGS and conventional methods (culture and PCR). Then, the type and number of detected pathogens, as well as the specificity and sensitivity, were compared between the two methods. In addition, the positive rates of bacteria, fungi, tubercle bacillus, and mixed infection in bronchoalveolar lavage fluid, sputum, pleural effusion, and blood detected by mNGS, and the advantage in required test time were evaluated. RESULTS More types and numbers of pathogens were detected by mNGS with a higher sensitivity but a lower specificity, as compared to the conventional detection methods (all P<0.05). The positive rates and integrity rates of bacteria, fungi, and tubercle bacillus detected by mNGS were higher than those by conventional methods (all P<0.05). Moreover, there was no difference in the overall sensitivity of mNGS among different sample types, but the sensitivities of mNGS in bronchoalveolar lavage fluid and sputum samples were significantly higher than those of conventional methods (both P<0.05). The average test time for mNGS was shorter than that of conventional methods. CONCLUSION mNGS can detect more types and numbers of pathogenic microorganisms, improve the detection sensitivity, and reduce the detection time in patients with pulmonary infection.
Collapse
Affiliation(s)
- Peng Wei
- Department of Pulmonary and Critical Care Medicine, The Eighth Affiliated Hospital of Guangxi Medical University & Guigang City People’s HospitalGuigang 537100, Guangxi Zhuang Autonomous Region, China
| | - Lijuan Wu
- Department of Ultrasound, The Eighth Affiliated Hospital of Guangxi Medical University & Guigang City People’s HospitalGuigang 537100, Guangxi Zhuang Autonomous Region, China
| | - Yu Li
- Department of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital of Guangxi Medical UniversityNanning 530007, Guangxi Zhuang Autonomous Region, China
| | - Jian’gang Shi
- Department of Clinical Laboratory, The Eighth Affiliated Hospital of Guangxi Medical University & Guigang City People’s HospitalGuigang 537100, Guangxi Zhuang Autonomous Region, China
| | - Yifeng Luo
- Department of Intensive Care Unit, The Eighth Affiliated Hospital of Guangxi Medical University & Guigang City People’s HospitalGuigang 537100, Guangxi Zhuang Autonomous Region, China
| | - Wenbin Wu
- Department of Pulmonary and Critical Care Medicine, The Eighth Affiliated Hospital of Guangxi Medical University & Guigang City People’s HospitalGuigang 537100, Guangxi Zhuang Autonomous Region, China
| | - Jiemei Feng
- Department of Pulmonary and Critical Care Medicine, The Eighth Affiliated Hospital of Guangxi Medical University & Guigang City People’s HospitalGuigang 537100, Guangxi Zhuang Autonomous Region, China
| |
Collapse
|
11
|
Systems-Based Approach for Optimization of Assembly-Free Bacterial MLST Mapping. Life (Basel) 2022; 12:life12050670. [PMID: 35629339 PMCID: PMC9147691 DOI: 10.3390/life12050670] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2022] [Revised: 04/24/2022] [Accepted: 04/25/2022] [Indexed: 12/02/2022] Open
Abstract
Epidemiological surveillance of bacterial pathogens requires real-time data analysis with a fast turnaround, while aiming at generating two main outcomes: (1) species-level identification and (2) variant mapping at different levels of genotypic resolution for population-based tracking and surveillance, in addition to predicting traits such as antimicrobial resistance (AMR). Multi-locus sequence typing (MLST) aids this process by identifying sequence types (ST) based on seven ubiquitous genome-scattered loci. In this paper, we selected one assembly-dependent and one assembly-free method for ST mapping and applied them with the default settings and ST schemes they are distributed with, and systematically assessed their accuracy and scalability across a wide array of phylogenetically divergent Public Health-relevant bacterial pathogens with available MLST databases. Our data show that the optimal k-mer length for stringMLST is species-specific and that genome-intrinsic and -extrinsic features can affect the performance and accuracy of the program. Although suitable parameters could be identified for most organisms, there were instances where this program may not be directly deployable in its current format. Next, we integrated stringMLST into our freely available and scalable hierarchical-based population genomics platform, ProkEvo, and further demonstrated how the implementation facilitates automated, reproducible bacterial population analysis.
Collapse
|
12
|
Hassett KJ, Higgins J, Woods A, Levy B, Xia Y, Hsiao CJ, Acosta E, Almarsson Ö, Moore MJ, Brito LA. Impact of lipid nanoparticle size on mRNA vaccine immunogenicity. J Control Release 2021; 335:237-246. [PMID: 34019945 DOI: 10.1016/j.jconrel.2021.05.021] [Citation(s) in RCA: 168] [Impact Index Per Article: 42.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2021] [Revised: 05/14/2021] [Accepted: 05/16/2021] [Indexed: 01/03/2023]
Abstract
Lipid nanoparticles (LNP) are effective delivery vehicles for messenger RNA (mRNA) and have shown promise for vaccine applications. Yet there are no published reports detailing how LNP biophysical properties can impact vaccine performance. In our hands, a retrospective analysis of mRNA LNP vaccine in vivo studies revealed a relationship between LNP particle size and immunogenicity in mice using LNPs of various compositions. To further investigate this, we designed a series of studies to systematically change LNP particle size without altering lipid composition and evaluated biophysical properties and immunogenicity of the resulting LNPs. While small diameter LNPs were substantially less immunogenic in mice, all particle sizes tested yielded a robust immune response in non-human primates (NHP).
Collapse
Affiliation(s)
- Kimberly J Hassett
- Moderna, Inc, 200 Technology Square, Cambridge, MA 02139, United States of America
| | - Jaclyn Higgins
- Moderna, Inc, 200 Technology Square, Cambridge, MA 02139, United States of America
| | - Angela Woods
- Moderna, Inc, 200 Technology Square, Cambridge, MA 02139, United States of America
| | - Becca Levy
- Moderna, Inc, 200 Technology Square, Cambridge, MA 02139, United States of America
| | - Yan Xia
- Moderna, Inc, 200 Technology Square, Cambridge, MA 02139, United States of America
| | - Chiaowen Joyce Hsiao
- Moderna, Inc, 200 Technology Square, Cambridge, MA 02139, United States of America
| | - Edward Acosta
- Moderna, Inc, 200 Technology Square, Cambridge, MA 02139, United States of America
| | - Örn Almarsson
- Moderna, Inc, 200 Technology Square, Cambridge, MA 02139, United States of America
| | - Melissa J Moore
- Moderna, Inc, 200 Technology Square, Cambridge, MA 02139, United States of America
| | - Luis A Brito
- Moderna, Inc, 200 Technology Square, Cambridge, MA 02139, United States of America.
| |
Collapse
|
13
|
Ding C, Liu X, Yang S. The value of infectious disease modeling and trend assessment: a public health perspective. Expert Rev Anti Infect Ther 2021; 19:1135-1145. [PMID: 33522327 DOI: 10.1080/14787210.2021.1882850] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
INTRODUCTION Disease outbreaks of acquired immunodeficiency syndrome, severe acute respiratory syndrome, pandemic H1N1, H7N9, H5N1, Ebola, Zika, Middle East respiratory syndrome, and recently COVID-19 have raised the attention of the public over the past half-century. Revealing the characteristics and epidemic trends are important parts of disease control. The biological scenarios including transmission characteristics can be constructed and translated into mathematical models, which can help to predict and gain a deeper understanding of diseases. AREAS COVERED This review discusses the models for infectious diseases and highlights their values in the field of public health. This information will be of interest to mathematicians and clinicians, and make a significant contribution toward the development of more specific and effective models. Literature searches were performed using the online database of PubMed (inception to August 2020). EXPERT OPINION Modeling could contribute to infectious disease control by means of predicting the scales of disease epidemics, indicating the characteristics of disease transmission, evaluating the effectiveness of interventions or policies, and warning or forecasting during the pre-outbreak of diseases. With the development of theories and the ability of calculations, infectious disease modeling would play a much more important role in disease prevention and control of public health.
Collapse
Affiliation(s)
- Cheng Ding
- State Key Laboratory for Diagnosis and Treatment of Infectious Diseases,National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Xiaoxiao Liu
- State Key Laboratory for Diagnosis and Treatment of Infectious Diseases,National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Shigui Yang
- State Key Laboratory for Diagnosis and Treatment of Infectious Diseases,National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.,Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
| |
Collapse
|
14
|
Yang K, Wang L, Li F, Chen D, Li X, Qiu C, Chen R. The influence of preventive strategies on the COVID-2019 epidemic in Shenzhen, China. Eur Respir J 2020; 55:13993003.00599-2020. [PMID: 32299861 PMCID: PMC7163720 DOI: 10.1183/13993003.00599-2020] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2020] [Accepted: 03/18/2020] [Indexed: 01/08/2023]
Affiliation(s)
- Kai Yang
- Dept of Respiratory and Critical Care Medicine, Shenzhen Key Laboratory of Respiratory Diseases, Shenzhen Institute of Respiratory Diseases, Second Clinical Medical College of Jinan University (Shenzhen people's Hospital), Shenzhen, China.,Dept of Respiratory and Critical Care Medicine, First Affiliated Hospital of South University of Science and Technology, Shenzhen, China.,Equal contribution
| | - Lingwei Wang
- Dept of Respiratory and Critical Care Medicine, Shenzhen Key Laboratory of Respiratory Diseases, Shenzhen Institute of Respiratory Diseases, Second Clinical Medical College of Jinan University (Shenzhen people's Hospital), Shenzhen, China.,Dept of Respiratory and Critical Care Medicine, First Affiliated Hospital of South University of Science and Technology, Shenzhen, China.,Equal contribution
| | - Furong Li
- Dept of Respiratory and Critical Care Medicine, Shenzhen Key Laboratory of Respiratory Diseases, Shenzhen Institute of Respiratory Diseases, Second Clinical Medical College of Jinan University (Shenzhen people's Hospital), Shenzhen, China.,Dept of Respiratory and Critical Care Medicine, First Affiliated Hospital of South University of Science and Technology, Shenzhen, China
| | - Dandan Chen
- Dept of Respiratory and Critical Care Medicine, Shenzhen Key Laboratory of Respiratory Diseases, Shenzhen Institute of Respiratory Diseases, Second Clinical Medical College of Jinan University (Shenzhen people's Hospital), Shenzhen, China.,Dept of Respiratory and Critical Care Medicine, First Affiliated Hospital of South University of Science and Technology, Shenzhen, China
| | - Xi Li
- Dept of Respiratory and Critical Care Medicine, Shenzhen Key Laboratory of Respiratory Diseases, Shenzhen Institute of Respiratory Diseases, Second Clinical Medical College of Jinan University (Shenzhen people's Hospital), Shenzhen, China.,Dept of Respiratory and Critical Care Medicine, First Affiliated Hospital of South University of Science and Technology, Shenzhen, China
| | - Chen Qiu
- Dept of Respiratory and Critical Care Medicine, Shenzhen Key Laboratory of Respiratory Diseases, Shenzhen Institute of Respiratory Diseases, Second Clinical Medical College of Jinan University (Shenzhen people's Hospital), Shenzhen, China.,Dept of Respiratory and Critical Care Medicine, First Affiliated Hospital of South University of Science and Technology, Shenzhen, China.,Equal contribution as senior author
| | - Rongchang Chen
- Dept of Respiratory and Critical Care Medicine, Shenzhen Key Laboratory of Respiratory Diseases, Shenzhen Institute of Respiratory Diseases, Second Clinical Medical College of Jinan University (Shenzhen people's Hospital), Shenzhen, China .,Dept of Respiratory and Critical Care Medicine, First Affiliated Hospital of South University of Science and Technology, Shenzhen, China.,Equal contribution as senior author
| |
Collapse
|
15
|
Olshan AF, Diez Roux AV, Hatch M, Klebanoff MA. Epidemiology: Back to the Future. Am J Epidemiol 2019; 188:814-817. [PMID: 30877290 DOI: 10.1093/aje/kwz045] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2019] [Revised: 02/11/2019] [Accepted: 02/15/2019] [Indexed: 12/14/2022] Open
Abstract
In 2018, the Society for Epidemiologic Research and its partner journal, the American Journal of Epidemiology, assembled a working group to develop a set of papers devoted to the "future of epidemiology." These 14 papers covered a wide range of topic areas and perspectives, from thoughts on our profession, teaching, and methods to critical areas of substantive research. The authors of those papers considered current challenges and future opportunities for research and education. In light of past commentaries, 4 papers also include reflections on the discipline at present and in the future.
Collapse
Affiliation(s)
- Andrew F Olshan
- Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, Chapel Hill North Carolina
| | - Ana V Diez Roux
- Urban Health Collaborative, Dornsife School of Public Health, Drexel University, Philadelphia, Pennsylvania
| | - Maureen Hatch
- Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
| | - Mark A Klebanoff
- Center for Perinatal Research, The Research Institute at Nationwide Children’s Hospital, Columbus, Ohio
| |
Collapse
|